29 Year Old Man with Multiple Sclerosis and Schizophrenia

A Case Report

Authors

  • Hamid Reza Ahmadkhaniha MD; Professor of Psychiatry, Department of Psychiatry, Iran University of Medical Science, Tehran, Iran

Keywords:

Multiple sclerosis (MS), Schizophrenia, Aripiprazole (Abilizol), Risperidone, Avonex

Abstract

Multiple sclerosis (MS) is the most common debilitating neurological disease that affects adults, whether young adults or middle-aged. Although, most attention is toward the neurological signs of the disease, the neuropsychiatric signs are not uncommon. This case report presents a 29 year old male with a record of obsessive-compulsive disorder (OCD) without psychotic disorder, which coincides with the diagnosis MS, has been stricken to auditory hallucinations and reference delusion. The patient received some antipsychotic drugs such as Haloperidol and Perphenazine irregularly, but any psychotic signs of the patient were never in control. During this period he had several active episodes of MS disease, wherein the symptoms had subsided due to hospitalization and received corticosteroids pulse. The first time the patient was submitted to the emergency unit of Rasoul Akram Hospital, there was the possibility of schizophrenia which was confirmed in subsequent visits. The signs of the patient were not controllable for a long time and finally fully controlled by a combination of Aripiprazole (abilizol), Risperidone and Sertraline, and currently, for almost 3 years, both psychotic symptoms and MS disease have been under control. Our patient seems to catch the MS disease and schizophrenia simultaneously. There was no relation between MS and psychosis episodes and the MS attacks. Since the onset the patient had several acute MS attacks of MS, and hospitalization several times. These findings and characteristics regarding our patient made him completely different from other reported cases of MS along with neuropsychiatric signs which may help doctors in diagnosis and managment of similar cases.

References

Yadav R, Zigmond AS. Temporal lobe lesions and psychosis in multiple sclerosis. BMJ Case Rep. 2010;

pii: bcr0120102651. doi: 10.1136/bcr.01.2010.2651. PMID: 22789690, PMCID: PMC3030118.

Figved N, Klevan G, Myhr KM, Glad S, Nyland H, Larsen JP, et al. Neuropsychiatric symptoms in patient

with multiple sclerosis. Acta Psychiatr Scand. 2005; 112(6): 463-8. doi: 10.1111/j.1600- 0447.2005.00624.x. PMID: 16279876.

Larsen JP, Aarli JA, Nyland H, Riise T. Western Norway, a high-risk area for multiple sclerosis: a

prevalence/incidence study in the county of Hordaland. Neurology. 1984; 34(9): 1202-7. PMID: 6540405.

Celius EG, Vandik B. Multiple sclerosis in oslo, Norway: Prevalence on 1 January 1995 and incidence over

a 25-year period. Eur J Neurol. 2001; 8(5): 463-9. PMID: 11554910.

Dahl OP, Aarseth JH, Myhr KM, Nyland H, Midgard R. Multiple sclerosis in Nord-Trøndelag County,

Norway: a prevalence and incidence study. Acta Neurol Scand. 2004; 109(6): 378-84. doi: 10.1111/j.1600- 0404.2004.00244.x. PMID: 15147459.

Goeb JL, Even C, Nicolas G, Gohier B, Dubas F, Garré JB. Psychiatric side effects of interferon- B in

multiple sclerosis. Eur Psychiatry. 2006; 21(3): 186-93. doi: 10.1016/j.eurpsy.2005.09.013. PMID:

Psychiatric symptoms According multiple sclerosis onset: A case Report. J Neuropsychiatry clin Neurosci.

; 26: 2.

Reiss JP, Sam D, Sareen J. Psychosis in multiple sclerosis associated with left temporal lobe lesions on

serial MRI scans. J Clin Neurosci. 2006; 13(2): 282-4. doi: 10.1016/j.jocn.2005.02.017. PMID: 16503492.

Feinstein A. Neuropsychiatric syndromes associated with multiple sclerosis. J Neurol. 2007; 254(2): II73-6.

doi: 10.1007/s00415-007-2017-2. PMID: 17503134.

Moghtaderi A, Rakhshanizadeh F, Shahraki-Ibrahimi S. Incidence and prevalence of multiplesclerosis in

southeastern Iran. Clin Neurol Neurosurg. 2013; 115(3): 304-8. doi: 10.1016/j.clineuro.2012.05.032.

PMID: 22717599.

O'Gorman C, Lin R, Stankovich J, Broadley SA. Modelling gentic susceptibility to multiplesclerosis with

family data. Neuroepidemiology. 2013; 40(1): 1-12. doi: 10.1159/000341902. PMID: 23075677.

Published

2022-03-07